[1]
|
GBD 2017 Pancreatic Cancer Collaborators (2019) The Global, Regional, and National Burden of Pancreatic Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology, 4, 934-947.
|
[2]
|
张敏, 徐杰茹, 陈磊, 等. 2005-2016年中国胰腺癌发病趋势及影响因素分析[J]. 中南医学科学杂志, 2022, 50(3): 358-361.
|
[3]
|
Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[4]
|
Oettle, H., Post, S., Neuhaus, P., et al. (2007) Adjuvant Chemotherapy with Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial. JAMA, 297, 267-277. https://doi.org/10.1001/jama.297.3.267
|
[5]
|
Luo, G., Jin K., Deng S., et al. (2021) Roles of CA19-9 in Pancreatic Cancer: Biomarker, Predictor, and Promoter. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1875, Article 188409. https://doi.org/10.1016/j.bbcan.2020.188409
|
[6]
|
田永, 王瑞勤, 常越, 等. 微小RNA-143、糖类抗原19-9在胰腺癌诊断和预后预测中的应用价值[J]. 癌症进展, 2022, 20(14): 1505-1508.
|
[7]
|
Edge, S.B. and Compton C.C. (2010) The American Joint Committee on Cancer: The 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Annals of Surgical Oncology, 17, 1471-1474. https://doi.org/10.1245/s10434-010-0985-4
|
[8]
|
Doll, K.M., Rademaker, A. and Sosa, J.A. (2018) Practical Guide to Surgical Data Sets: Surveillance, Epidemiology, and End Results (SEER) Database. JAMA Surgery, 153, 588-589. https://doi.org/10.1001/jamasurg.2018.0501
|
[9]
|
Van Calster, B., Wynants, L., Verbakel, J.F.M., et al. (2018) Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators. European Urology, 74, 796-804. https://doi.org/10.1016/j.eururo.2018.08.038
|
[10]
|
Okusaka, T. (2022) Treatment for Postoperative Recurrence of Pancreatic Cancer: A Narrative Review. Chinese Clinical Oncology, 11, Article 19. https://doi.org/10.21037/cco-21-87
|
[11]
|
Tanaka, M., Mihačević, A.L., Probst, P., et al. (2019) Meta-Analysis of Recurrence Pattern after Resection for Pancreatic Cancer. British Journal of Surgery, 106, 1590-1601. https://doi.org/10.1002/bjs.11295
|
[12]
|
王若尘, 吴德全. 复发性胰腺癌的预测及治疗的研究进展[J]. 医学研究生学报, 2020, 33(5): 555-560.
|
[13]
|
Iasonos, A., Schrag, D., Raj, G.V., et al. (2008) How to Build and Interpret a Nomogram for Cancer Prognosis. Journal of Clinical Oncology, 26, 1364-1370. https://doi.org/10.1200/JCO.2007.12.9791
|
[14]
|
赛麦提喀日·阿布都巴日, 梅玉洁, 安恒庆, 等. 基于SEER数据库构建前列腺癌术后生存率预测模型[J]. 现代预防医学, 2022, 49(21): 4026-4032.
|
[15]
|
冯程程, 许传志, 何杰宇, 等. 1990-2019年中国20~84岁人群胰腺癌发病趋势分析[J]. 中华肿瘤防治杂志, 2022, 29(18): 1323-1329.
|
[16]
|
Yin, L., Xiao, L., Gao, Y., et al. (2020) Comparative Bioinformatical Analysis of Pancreatic Head Cancer and Pancreatic Body/Tail Cancer. Medical Oncology, 37, Article No. 46. https://doi.org/10.1007/s12032-020-01370-0
|
[17]
|
Adachi, E., Maehara, S., Tsujita, E., et al. (2002) Clinicopathologic Risk Factors for Recurrence after a Curative Hepatic Resection for Hepatocellular Carcinoma. Surgery, 131, S148-S152. https://doi.org/10.1067/msy.2002.119496
|
[18]
|
Erdem, S., Bölükbaş, M., Müller, S.A., et al. (2020) Role of Lymphadenectomy in Resectable Pancreatic Cancer. Langenbeck’s Archives of Surgery, 405, 889-902. https://doi.org/10.1007/s00423-020-01980-2
|
[19]
|
张世祥. 影响胰头癌切除术后患者预后的相关因素分析[D]: [硕士学位论文]. 银川: 宁夏医科大学, 2020.
|
[20]
|
Springerfeld, C., Jäger, D., Büchler, M.W., et al. (2019) Chemotherapy for Pancreatic Cancer. Presse Médicale, 48, e159-e174. https://doi.org/10.1016/j.lpm.2019.02.025
|
[21]
|
Brunner, T.B., Haustermans, K., Huguet, F., et al. (2021) ESTRO ACROP Guidelines for Target Volume Definition in Pancreatic Cancer. Radiotherapy and Oncology, 154, 60-69. https://doi.org/10.1016/j.radonc.2020.07.052
|
[22]
|
Yeo, C.J., Abrams, R.A., Grochow, L.B., et al. (1997) Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves Survival. A Prospective, Single-Institution Experience. Annals of Surgery, 225, 621-633. https://doi.org/10.1097/00000658-199705000-00018
|
[23]
|
Chiang, K.C., Yeh, C.N., Lee, W.C., et al. (2009) Prognostic Analysis of Patients with Pancreatic Head Adenocarcinoma Less Than 2 cm Undergoing Resection. World Journal of Gastroenterology, 15, 4305-4310. https://doi.org/10.3748/wjg.15.4305
|
[24]
|
Satake, K., Chung, Y.S., Umeyama, K., et al. (1991) The Possibility of Diagnosing Small Pancreatic Cancer (Less Than 4.0 cm) by Measuring Various Serum Tumor Markers: A Retrospective Study. Cancer, 68, 149-152. https://doi.org/10.1002/1097-0142(19910701)68:1<149::AID-CNCR2820680127>3.0.CO;2-9
|
[25]
|
Chen, Y., Gao, S.G., Chen, J.M., et al. (2015) Serum CA242, CA199, CA125, CEA, and TSGF Are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients. Cell Biochemistry and Biophysics, 71, 1287-1291. https://doi.org/10.1007/s12013-014-0345-2
|